Cargando…

Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma is one of the most common malignant tumors in the digestive system in China and the world. Most patients are diagnosed as locally advanced or advanced stage. Concurrent chemoradiotherapy is the standard treatment for locally advanced esophageal squamous cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiao-Fei, Liu, Pei-Yi, Zhang, Shu-Juan, Zhao, Kuai-Le, Zhao, Wei-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Evidence Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782941/ https://www.ncbi.nlm.nih.gov/pubmed/36569017 http://dx.doi.org/10.12998/wjcc.v10.i35.12804

Ejemplares similares

Progress on haptoglobin and metabolic diseases
por: Wan, Bao-Nian, et al.
Publicado: (2021)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

Comparison and Prognostic Analysis of Adjuvant Radiotherapy versus Salvage Radiotherapy for Treatment of Radically Resected Locally Advanced Esophageal Squamous Cell Carcinoma
por: Xu, Xin, et al.
Publicado: (2016)

Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria?
por: D'Souza, Steve M, et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
por: Chen, Fei, et al.
Publicado: (2022)

Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma
por: Luo, Hua-Chun, et al.
Publicado: (2023)

Anti-VEGF drugs: evidence for effectiveness
por: Evans, Jennifer, et al.
Publicado: (2014)

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014)

The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Lv, Huilai, et al.
Publicado: (2023)

Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma
por: Lu, Jun-Tao, et al.
Publicado: (2023)

An integrative review of leadership competencies and attributes in advanced nursing practice
por: Heinen, Maud, et al.
Publicado: (2019)

Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
por: Jia, Ru, et al.
Publicado: (2021)

Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Wang, Ruixi, et al.
Publicado: (2022)

The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
por: Er, Puchun, et al.
Publicado: (2020)

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Meng, Jin, et al.
Publicado: (2018)

Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
por: Gautam, Gagan
Publicado: (2014)

Treatment beyond progression with chemo-immunotherapy in an advanced esophageal squamous cell carcinoma patient: a case report
por: Peng, Ping, et al.
Publicado: (2021)

Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma
por: Wang, Xin, et al.
Publicado: (2022)

USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP
por: Zhang, Wenhao, et al.
Publicado: (2022)

Is laparoscopic approach safe for radical nephrectomy for tumors larger than 7 cm?
por: Jain, Paresh, et al.
Publicado: (2008)

Ureteral frozen section analysis during radical cystectomy: Do margins matter?
por: Mukha, Rajiv, et al.
Publicado: (2007)

CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy
por: Yan, Shuo, et al.
Publicado: (2023)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Oh, Dongryul, et al.
Publicado: (2020)

A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy
por: Ou, Zhengjie, et al.
Publicado: (2021)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

Anti-apoptotic effect of banhasasim-tang on chronic acid reflux esophagitis
por: Shin, Mi-Rae, et al.
Publicado: (2017)

Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials
por: Wang, Qinxue, et al.
Publicado: (2016)

Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
por: Liu, Xuejiao, et al.
Publicado: (2023)

Value of CT and (18)F-FDG PET/CT Imaging for Preoperative Screening in Advanced Heart Failure Therapy Candidates
por: Rabbath, Xavier, et al.
Publicado: (2023)

Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma
por: Lin, Ming-qiang, et al.
Publicado: (2020)

Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma
por: Yang, Yu‐Xian, et al.
Publicado: (2022)

Prostatic fascia and recovery of sexual function after radical prostatectomy: Is it a “Veil of Aphrodite” or “Veil of mystery”!
por: Mandhani, Anil
Publicado: (2009)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma
por: Huang, Yuting, et al.
Publicado: (2022)

Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer
por: Wang, Yichun, et al.
Publicado: (2020)

Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world
por: Zhang, Pei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lml56s17rgjt5h9gsb79grdq9u